Quintana, D S
Westlye, L T
Rustan, Ø G
Tesli, N
Poppy, C L
Smevik, H
Tesli, M
Røine, M
Mahmoud, R A
Smerud, K T
Djupesland, P G
Andreassen, O A
Article History
Received: 2 June 2015
Accepted: 2 June 2015
First Online: 14 July 2015
Competing interests
: PGD is an employee of OptiNose AS, Oslo, Norway and owns stock and stock options in OptiNose. RAM is an employee of OptiNose US, Yardley, PA, USA and owns stock and stock options in OptiNose. OAA has received speaker’s honoraria from GSK, Lundbeck and Otsuka for work not directly relevant to the submitted manuscript. MT has received speaker’s honorarium from Medivir for work not directly relevant to the submitted manuscript. MR and KTS are employed (and KTS owner) by Smerud Medical Research International AS, a CRO receiving fees for clinical trial services from OptiNose AS. The remaining authors declare no conflict of interest.